BIOALPHA HOLDINGS BERHAD

KLSE (MYR): BIOHLDG (0179)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

0.095

Today's Change

-0.005 (5.00%)

Day's Change

0.09 - 0.095

Trading Volume

2,955,800


14 people like this.

20,642 comment(s). Last comment by corpsehunter69 1 day ago

jt18

252 posts

Posted by jt18 > 2023-10-07 20:15 | Report Abuse

Haiz. Really hopeless …

jupiter

1,518 posts

Posted by jupiter > 2023-10-12 10:38 | Report Abuse

浪费时间浪费金钱投资在这只烂股

Posted by Wong Kah Wei > 2023-10-12 22:43 | Report Abuse

真的烂臭股,老板就只会印股票骗钱。

khpwwl

3,393 posts

Posted by khpwwl > 2023-10-18 10:08 | Report Abuse

big K already know outside lots of ppl still holding this tickets ard 0.20+- issue pp dilute share price and convert it again...

Posted by mrkhoi306 > 2023-10-26 15:49 | Report Abuse

Big sc*mmers... BIOHLDG

sunsetbiz

730 posts

Posted by sunsetbiz > 2023-11-02 10:40 | Report Abuse

the boss is accountant which not good in biz only good in money printing lol..:)

Posted by Jollyjoe65 > 2023-11-23 17:36 | Report Abuse

avoid this company at all cost

RoyRoy

9 posts

Posted by RoyRoy > 2 months ago | Report Abuse

Wah, almost 10cents

Posted by dwayne1109 > 2 months ago | Report Abuse

Just read about Bioalpha's new project - an agro park in Langkawi. Focused on sustainability, which is pretty cool. Also seems like it could be a boost for the community there.

Posted by sitisaham > 2 months ago | Report Abuse

just saw news Bioalpha appointed by Langkawi Development Authority to develop and manage 8-acre agro park in langkawi.. will be ready in 3 years.. new revenue stream for Bioalpha?
maybe potential to be new tourist hot spot in langkawi..

The Edge: Bioalpha appointed to develop agro park in Langkawi

https://theedgemalaysia.com/node/692592

KUALA LUMPUR (Dec 4): Bioalpha Holdings Bhd said that its wholly-owned subsidiary has been appointed by the Langkawi Development Authority (Lada) to develop and operate a 7.98-acre agro park in Bandar Padang Mat Sirat, Langkawi.

“Bioalpha Wellness Sdn Bhd’s scope is to develop the project and upon completion, will undertake the management and operations of the park,” the integrated health supplement group said in a filing on Monday.

As the owner of the land, Lada — an agency under the Ministry of Finance tasked to propel the tourism economy of Langkawi — is granting Bioalpha Wellness rights of land use for 30 years, said Bioalpha.

Bioalpha Wellness, meanwhile, will provide Lada with a yearly fixed fee and quit rent and assessment. The company will also provide an estimated investment of at least RM15 million to be funded by internally generated funds and bank borrowings.

As of December 2022, Bioalpha’s cash balances stood at RM39.8 million.

Bioalpha said development of the agro park will commence immediately, with the opening targeted in three years.

“Bioalpha plans to develop the park showcasing the integrated facility encompassing the full spectrum of the supply chain, from herbal farming, research and development to product processing.

“One of the park’s attractions will be the herbal garden featuring a smart greenhouse with over 300 high-value crop varieties, where visitors can actively participate in planting and harvesting activities,” the company said in a statement, adding that the park is also capable of catering to international meetings, incentives, conferences, and exhibitions (Mice) events related to herbal farming and agriculture.

Shares in Bioalpha closed half a sen or 5.56% lower to 8.5 sen on Monday, giving the group a market capitalisation of RM119.55 million. Year to date, the counter has declined 22.73%.

----

The Star: Bioalpha to develop an 8-acre agro park in Langkawi

https://www.thestar.com.my/business/business-news/2023/12/04/bioalpha-to-develop-an-8-acre-agro-park-in-langkawi

KUALA LUMPUR: Bioalpha Holdings Bhd’s wholly-owned subsidiary, Bioalpha Wellness Sdn Bhd has entered into a manage and operate agreement with the Langkawi Development Authority (LADA) to develop, manage, and operate an agro park in Langkawi, Kedah (Langkawi Agro Park).

LADA is an agency under the Ministry of Finance, tasked to propel the tourism economy of Langkawi to advance the island to become a world-renowned tourist destination.

The integrated health supplement company, in a statement, said the proposed park would be built on an 8-acre land situated in a prime location at Padang Matsirat, approximately 1 km away from the Langkawi International Airport.

Under the agreement, LADA as the landowner, shall grant Bioalpha the land use rights for 30 years effective from the signing date. Bioalpha’s scope is to develop the agro park and upon completion, it will undertake the management and operations of the park.

Bioalpha plans to develop the park showcasing the integrated facility encompassing the full spectrum of the supply chain, from herbal farming, and R&D to product processing.

“Development of the park is slated to commence immediately, with the park opening targeted in two years.

“The estimated investment of at least RM15mil by Bioalpha will be funded by internally generated funds and bank borrowings. As at Dec 31, 2022, Bioalpha has robust cash balances of RM39.8mil,” it said.

“We are eager to commence works and expect contributions from the park starting in 2027. With a diverse range of attractions, we are confident that the park will be enthusiastically embraced by the public,” Bioalpha managing director William Hon said.

He said the development enabled the group to broaden its revenue streams from various sources such as admission fees to the park, commercialisation of more than 100 high-value herbal products packaged in Langkawi-inspired branding, in addition to in-park collections from the sale of products, and food and beverages (F&B).

“At the same time, we aim to tap into our agricultural expertise to promote and educate about Malaysia’s high-value herbs to both local and international tourists. Our goal is to create a holistic edutainment experience for visitors, where they can gain greater cultural and learning awareness through the activities,” Hon said.

RoyRoy

9 posts

Posted by RoyRoy > 2 months ago | Report Abuse

copy paste so much also cant chance the fact the company is garbage

Cadfael

156 posts

Posted by Cadfael > 2 months ago | Report Abuse

That's old news. This is just window dressing. It will take about three years before it can generate income. We can expect more rights issue or private placement in the future. We have the same news as the R&D park in China which will only be operational between 3 - 5 years from now. There's not even a projected expected revenue. You can expect the price to stay the same or go lower if the revenue stagnates. However, the report says the company expects the revenue to improve going forward. We will see whether this will materialise.

khpwwl

3,393 posts

Posted by khpwwl > 2 months ago | Report Abuse

goreng goreng...tp 0.13 1st

Cadfael

156 posts

Posted by Cadfael > 2 months ago | Report Abuse

Another China project awarded? 😂

smartly

6,326 posts

Posted by smartly > 2 months ago | Report Abuse

assuming......e.g
1. you have 8,000 shares @ 0.10 = RM800
2. your cost for warrants 3000 x 0.03 = RM90
3. ex-priced for BIO = 0.1 & BIO-W issue = 0.03
4. you need mother to be @ 0.14 and above in order to have some small value of the RI-W to subscribe else not worth

Cadfael

156 posts

Posted by Cadfael > 2 months ago | Report Abuse

One day show. Just like a one-trick pony

sting79

754 posts

Posted by sting79 > 2 months ago | Report Abuse

The new warrants has a fair value of 0.0575 for an issue price of 0.035. Many may think that it is a nice 39% discount, so maybe worth to subscribe the rights at 0.035.

But if take into consideration BIO is nearly 'dead' with no interest from new investors/retailers, it is not hard to notice the small fake push resulting in the 5D-VWAP of 0.1088 per share. This 5 day average price is what determines the warrant's fair value of 0.0575.

If you have subscribed rights before, you may know this is not the only choice to average down OR interested for a quick capital appreciation. The mother will be adjusted accordingly after ex-date for sure, so that is one way to average down at that time or for new comers to buy mother. Just do some maths and you realized the amount paid from buying in open market is very similar to subscribing the rights.

Personally, this kind of stock is not worth putting your hard earn money to support any exercise, rather play the wait-and-see game during and after ex-date. Without China players to support, it would be a rather refreshing sight to see the price goes up and up supported by the local players.

sting79

754 posts

Posted by sting79 > 2 months ago | Report Abuse

smartly
assuming......e.g
1. you have 8,000 shares @ 0.10 = RM800
2. your cost for warrants 3000 x 0.03 = RM90
3. ex-priced for BIO = 0.1 & BIO-W issue = 0.03
4. you need mother to be @ 0.14 and above in order to have some small value of the RI-W to subscribe else not worth

Even if mother can be pushed above 0.14, still need time to convert the warrant... another point to consider...

Posted by corpsehunter69 > 1 month ago | Report Abuse

how to profit???

stampid54

232 posts

Posted by stampid54 > 1 month ago | Report Abuse

If didn't subscribe to its right issue, will it reduce our number of shares that bought?

sting79

754 posts

Posted by sting79 > 1 month ago | Report Abuse

After ex-date, the mother price will be adjusted lower. If you didn't subscribe, it means the worth of your BIO shares will be reduced. You can however buy the mother share from open market after ex-date for the same amount you need to pay for rights issue.

For example let's say you need fork out RM1000 for rights issue. You can instead choose to buy RM1000 worth of mother shares from open market after ex-date.

The total worth (both mother and warrant from rights issue) if you subscribe VERSUS the total worth (mother only) if you buy from open market should be quite similar.

The subscription has advantages where you will get warrants to play with and also helping to inject money into company. But then I can also choose to buy warrant from open market after ex-date if want to play with warrants.

Ultimately, up to you if want to support the company in its exercise. Personally, if company does not support its price, you should not waste money also.

khpwwl

3,393 posts

Posted by khpwwl > 1 month ago | Report Abuse

rubbish company...better avoid

sunsetbiz

730 posts

Posted by sunsetbiz > 1 month ago | Report Abuse

selling to get more new shares soon at lower price lol....:)

Vhydro

1,546 posts

Posted by Vhydro > 1 month ago | Report Abuse

Rubbish people talking rubbish

smartly

6,326 posts

Posted by smartly > 1 month ago | Report Abuse

if BIOHLDG closed anything below 0.135, then better don't subscribe the Warrant Rights

sting79

754 posts

Posted by sting79 > 1 month ago | Report Abuse

For those not subscribing, don't forget to sell your rights share (trading starts tomorrow until next Friday).

Posted by corpsehunter69 > 1 month ago | Report Abuse

Run lor!

VinAlag

8 posts

Posted by VinAlag > 1 month ago | Report Abuse

Folks want an opinion. What do I do with the WR? I got it for free since i anyway own some BIO shares. I read somewehre that this is valid only till next friday. Sorry noob question

Posted by PennyStock123 > 1 month ago | Report Abuse

VinAlag......just sell it.....i sold mine orady today at 0.005....

khpwwl

3,393 posts

Posted by khpwwl > 1 month ago | Report Abuse

i wouldn't subscribe...rubbish company always rubbish...need your monies only. let themselves to pay for they own, we just wait within 3 years goreng mother share and sell all back to them

smartly

6,326 posts

Posted by smartly > 1 month ago | Report Abuse

just sell the wr while you still can. no point keeping.
mother needs to be 14sen only worth subscribe the rights else just sell

VinAlag

8 posts

Posted by VinAlag > 1 month ago | Report Abuse

wait im a bit lost...i didnt subsribe for it...it just appeared in my trading account..will they be back charging for it? im a bit lost sorry

smartly

6,326 posts

Posted by smartly > 1 month ago | Report Abuse

worry not. just sell to the market. this is just the warrant rights you entitle for holding on to mother.
quickly sell it while it is still available (0.005). later probably worth nothing

smartly

6,326 posts

Posted by smartly > 1 month ago | Report Abuse

gg liao. now want to sell also can't. need to queue.

buku555

56 posts

Posted by buku555 > 1 month ago | Report Abuse

to subscribe the warrants need to put in 13.5 sens, mean the mother share will go higher than 13.5 sens soon ?

young man

45 posts

Posted by young man > 1 month ago | Report Abuse

check the history of the company. see how was the warrant holder and pa holder being treated. avoid this counter

khpwwl

3,393 posts

Posted by khpwwl > 1 month ago | Report Abuse

nobody interested

MZM2511

4,394 posts

Posted by MZM2511 > 1 month ago | Report Abuse

i'm a newbie @this counter. Feels interested @ this company's warrant issuance....

Anyways, I think base on my study on Biohldg fundamental, I made a conclusion that this company won't be succumb to GN3 in a near future. The company is improving its pofitabilty...

1. NTA 10.85 sen.
2. NOSH 1.406 bilion.

3. EQUITY
Share capital RM 186,014,000
Reserves (RM 39,795,000)
Equity attributable to owners of the parent RM 146,219,000
Non-controlling interests RM 3,353,000
TOTAL EQUITY RM 149,572,000

4. Cash and Cash Equivalent:
Fixed deposit with licensed bank RM 1,018,000
Cash and bank balances RM 9,597,000

5. Assets:
Non-current Assets RM 138,443,000
(Note: Including investment in quoted shares RM 23,532,000)
Current Assets RM 56,258,000
TOTAL ASSETS RM 194,701,000

6. Liabilities:
Current Liabilities RM 12,385,000
Non-current liabilities RM 32,744,000
TOTAL LIABILITIES RM 45,129,000

7. Last QR result-Net loss (RM2,760,000)
Note 1:
The Group’s current quarter revenue for the financial period ended 30 September 2023 (“3QFY23”) grew by 61.3% year-on-year (“YoY”) to RM11.7 million, as compared to RM7.3 million in the preceding year’s corresponding quarter (“3QFY22”). The growth was driven by improved performance across all the Group’s segments

Note 2:
The Group’s revenue for the 3QFY23 increased by 37.7% to RM11.7 million, against RM8.5 million in the second (2nd) quarter ended 30 June 2023.

Note 3:
Meanwhile, turnover for the Group’s supply of health foods to China more than doubled to RM3.0 million in 3QFY23 (2QFY23: RM1.4 million) as deliveries to customers picked up. For our retail pharmacy business, revenue grew by 76.8% to RM5.4 million, from RM3.1 million in 2QFY23, on the back of contributions from newly opened pharmacy outlets.

MZM2511

4,394 posts

Posted by MZM2511 > 1 month ago | Report Abuse

Important dates to read and digest. For those who want to speculate, can use it as an important information. TAYOR.
---------------------
Date for commencement of trading of rights 12 Jan 2024
Date for cessation of trading of rights 19 Jan 2024
Date for announcement of final subscription result and basis of allotment of excess Rights Securities 06 Feb 2024
Last date and time for :
Sale of provisional allotment of rights 18 Jan 2024 05:00 PM
Transfer of provisional allotment of rights 22 Jan 2024 04:30 PM
Acceptance and Payment 29 Jan 2024 05:00 PM
Excess share application and payment 29 Jan 2024 05:00 PM
Available/Listing Date 14 Feb 2024

Vhydro

1,546 posts

Posted by Vhydro > 1 month ago | Report Abuse

I like the venture into pharmacy retain store biz instead of just focusing on manufacturing and supplying health supplement

MZM2511

4,394 posts

Posted by MZM2511 > 1 month ago | Report Abuse

To make sure the warrant issuance exercise successful, the price of the mother share SHOULD be more than 13.5 sen!!!
Just my DREAM... TAYOR

18 Jan - 29 Jan for me are the important dates..... to monitor

MZM2511

4,394 posts

Posted by MZM2511 > 1 month ago | Report Abuse

Hope in incoming one or two days of trading, it can test the highest price in a year @14 sen. TAYOR

https://www.tradingview.com/symbols/MYX-BIOHLDG/technicals/

MZM2511

4,394 posts

Posted by MZM2511 > 1 month ago | Report Abuse

Closed @11 sen.... Towards 14 sen????

buku555

56 posts

Posted by buku555 > 1 month ago | Report Abuse

Close 12 sens today!!!!!

sting79

754 posts

Posted by sting79 > 4 weeks ago | Report Abuse

Note 3 from latest financial reports:
For our retail pharmacy business, revenue grew by 76.8% to RM5.4 million, from RM3.1 million in 2QFY23, on the back of contributions from newly opened pharmacy outlets.

Newly opened pharmacy outlets? Let's dig some info:

1. Constant Pharmacy has been around for about 20 years now. It is a government-linked brand which enjoys support from Bioalpha Holdings Berhad. To date, it has grown to more than 13 outlets mostly around the Klang Valley.
Google search returned 15 outlets, and this is for over 20 years? AA pharmacy, Alpro pharmacy, Multicare pharmacy and Health Lane pharmacy which are not well known has at least 50 or more shops in Malaysia.

2. Constant Pharmacy in Shopee has extremely low volume of overall items sold:
-- Top item is apple cider vinegar sold for 2900+
-- Second top item is Panadol for 300+
Shopee may not constitute a big part of the sales, but still a very sad number if you look at the overall number of items sold.

3. LinkedIn company size for Constant pharmacy shows:
-- 51-200 employees
-- 39 associated members (members who’ve listed Constant Pharmacy as their current workplace on their profile.)
AA pharmacy, Alpro pharmacy, Multicare pharmacy and Health Lane pharmacy has at least 4 times in terms of associated members, and also at least 200 to >1000 employees.

sting79

754 posts

Posted by sting79 > 4 weeks ago | Report Abuse

Note 3 from latest financial reports:
Meanwhile, turnover for the Group’s supply of health foods to China more than doubled to RM3.0 million in 3QFY23 (2QFY23: RM1.4 million) as deliveries to customers picked up.

In the China agreement, BIO announced the contract to be worth $$$ per year:
The value of supplying health food and nutritional meals supplied is approximately RMB700,000,000 per year (equivalent to RM426,700,000).

In a query from Bursa, BIO replied:
Query: The basis and justification in arriving the value of the health food and nutritional meals to be supplied of approximately RMB700,000,000 per year (equivalent to RM426,700,000).
Reply: The supply contract value of RMB700,000,000 was offered by GYHX based on their requirements to meet the market consumption (public and private sector) based on its high population and health conscious awareness of the health food and nutritional meals.

The turnover of one quarter in 3QFY23 is 3 million, and yet the estimated supply value is 106 million a quarter?

MZM2511

4,394 posts

Posted by MZM2511 > 4 weeks ago | Report Abuse

The Group’s QR3 2023 revenue based on the geographical location of its customers is presented as follows:

Malaysia RM8,633,000
Indonesia RM14,000
China RM3,029,000
Others RM44,000
Total RM11,720,000
Note:
Revenue from Malaysia QR3 2023 up 40% from RM5,133,000 in QR3 2022.
Revenue from China also up 56% from RM1,943,000 in QR3 2022.

sunsetbiz

730 posts

Posted by sunsetbiz > 3 weeks ago | Report Abuse

the accts figures mainly made by Accountant CEO to attract water fish lol....

MZM2511

4,394 posts

Posted by MZM2511 > 3 weeks ago | Report Abuse

Burnt some here......
For the sake of an experiment on a new counter..
Sorry guys... In facts, the information is still valid..
But this counter is not suitable for me to play... He He He

Posted by corpsehunter69 > 1 day ago | Report Abuse

goreng stock, what can you do

Post a Comment
Market Buzz